FBLGFibroBiologics, Inc.

Nasdaq fibrobiologics.com


$ 4.41 $ 0.18 (4.26 %)    

Friday, 05-Jul-2024 09:48:44 EDT
QQQ $ 492.96 $ 1.22 (0.25 %)
DIA $ 392.29 $ -0.35 (-0.09 %)
SPY $ 551.44 $ -0.35 (-0.06 %)
TLT $ 91.99 $ -0.09 (-0.1 %)
GLD $ 219.70 $ 0.19 (0.09 %)
$ 4.23
$ 4.43
$ 0.00 x 0
$ 0.00 x 0
$ 4.41 - $ 4.45
$ 3.90 - $ 55.00
110,240
na
131.7M
$ -3.46
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-14-2024 03-31-2024 10-Q
2 02-29-2024 12-31-2023 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

- SEC Filing

Core News & Articles

Company Holds 150+ Patents For Fibroblast-Based Therapeutics And Cures For Chronic Diseases

Core News & Articles

- SEC Filing

Core News & Articles

This agreement comes ahead of entering into an anticipated master services agreement for the development and manufacture of Fib...

Core News & Articles

FibroBiologics, Inc. (NASDAQ:FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued ...

Core News & Articles

FibroBiologics, Inc., (NASDAQ:FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued...

Core News & Articles

FibroBiologics, Inc., (NASDAQ:FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued...